KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 137 filers reported holding KRYSTAL BIOTECH INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $5,000 | -90.0% | 69 | -90.9% | 0.00% | -88.0% |
Q1 2022 | $50,000 | +38.9% | 757 | +47.6% | 0.02% | +47.1% |
Q4 2021 | $36,000 | +56.5% | 513 | +16.9% | 0.02% | +13.3% |
Q3 2021 | $23,000 | -51.1% | 439 | -36.8% | 0.02% | -50.0% |
Q2 2021 | $47,000 | +161.1% | 695 | +202.2% | 0.03% | 0.0% |
Q1 2021 | $18,000 | – | 230 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 771,250 | $53,949,000 | 4.15% |
First Light Asset Management, LLC | 680,170 | $47,578,000 | 3.41% |
ACT CAPITAL MANAGEMENT, LLC | 59,000 | $4,127,000 | 2.98% |
S Squared Technology, LLC | 95,215 | $6,660,000 | 2.98% |
Redmile Group, LLC | 1,820,898 | $127,372,000 | 2.90% |
Soleus Capital Management, L.P. | 228,437 | $15,979,000 | 1.60% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 50,922 | $3,562,000 | 1.59% |
Artal Group S.A. | 700,000 | $48,965,000 | 1.33% |
SILVERARC CAPITAL MANAGEMENT, LLC | 46,670 | $3,265,000 | 1.32% |
Kynam Capital Management, LP | 34,816 | $2,435,000 | 1.30% |